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Background. Gut bacteria trigger colitis in animal models and are suspected to aggravate inflammatory bowel diseases. We
have recently reported that Escherichia coli accumulates in murine ileitis and exacerbates small intestinal inflammation via
Toll-like receptor (TLR) signaling. Methodology and Principal Findings. Because knowledge on shifts in the intestinal
microflora during colitis is limited, we performed a global survey of the colon flora of C57BL/10 wild-type (wt), TLR2
-/-, TLR4
-/-,
and TLR2/4
-/- mice treated for seven days with 3.5% dextrane-sulfate-sodium (DSS). As compared to wt animals, TLR2
-/-, TLR4
-/-,
and TLR2/4
-/- mice displayed reduced macroscopic signs of acute colitis and the amelioration of inflammation was associated
with reduced IFN-gamma levels in mesenteric lymph nodes, lower amounts of neutrophils, and less FOXP3-positive T-cells in
the colon in situ. During acute colitis E. coli increased in wt and TLR-deficient mice (P,0.05), but the final numbers reached
were significantly lower in TLR2
-/-, TLR4
-/- and TLR2/4
-/- animals, as compared to wt controls (P,0.01). Concentrations of
Bacteroides/ Prevotella spp., and enterococci did not increase during colitis, but their numbers were significantly reduced in
the colon of DSS-treated TLR2/4
-/- animals (P,0.01). Numbers of lactobacilli and clostridia remained unaffected by colitis,
irrespective of the TLR-genotype of mice. Culture-independent molecular analyses confirmed the microflora shifts towards
enterobacteria during colitis and showed that the gut flora composition was similar in both, healthy wt and TLR-deficient
animals. Conclusions and Significance. DSS-induced colitis is characterized by a shift in the intestinal microflora towards pro-
inflammatory Gram-negative bacteria. Bacterial products exacerbate acute inflammation via TLR2- and TLR4-signaling and
direct the recruitment of neutrophils and regulatory T-cells to intestinal sites. E. coli may serve as a biomarker for colitis
severity and DSS-induced barrier damage seems to be a valuable model to further identify bacterial factors involved in
maintaining intestinal homeostasis and to test therapeutic interventions based upon anti-TLR strategies.
Citation: Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, et al (2007) Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates
Acute Murine Colitis via Toll-like Receptors 2 and 4. PLoS ONE 2(7): e662. doi:10.1371/journal.pone.0000662
INTRODUCTION
In inflammatory bowel diseases (IBD) the disturbance of intestinal
barrier functions results in increased immunoreactivity against
bacterial antigens [1–3]. Patients with active intestinal inflamma-
tion display accumulation of commensal Escherichia coli or Bacteroides
spp. at inflamed tissue sites [4–6]. These bacterial groups, also
suspected to trigger intestinal inflammation in acute graft-versus-
host-disease after bone marrow transplantation [7], can further
potentiate immunopathology by translocation via microlesions and
ulcerations [5,8]. The role of the commensal intestinal microflora
in colitis has been studied in a number of experimental models
[9,10], but detailed knowledge on the gut microbiota composition
in acute intestinal inflammation is still limited. Recently, we have
demonstrated that acutemurine ileitis is accompanied bya rigorous
E. coli overgrowth in the terminal ileum. During acute in-
flammation, E. coli numbers increased by up to nine orders of
magnitude and their presence was found to be essential for the
induction and progression of ileal immunopathology [8]. High
numbers of E. coli in the inflamed ileum point towards an important
role of bacterial lipopolysaccharide (LPS) in the exacerbation of
acute intestinal inflammation. LPS and products from Gram-
positive bacteria are recognized by toll-like-receptors (TLRs) 4 and
2, respectively, both of which are expressed in the murine intestinal
mucosa [11]. Similar observations have been made in human IBD
where TLRs are upregulated at inflamed tissue sites [12,13]. In line
with this, we found that LPS-mediated TLR4 signaling is
responsible for a major part of the immunostimulatory potential
of E. coli in acute ileitis, whereas TLR2, the main receptor for
Gram-positive bacteria, was not involved [14].
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sulfate-sodium (DSS) is exacerbated by gut bacteria, as evidenced
by the amelioration of inflammation in germ-free animals and in
mice treated with antibiotics [15]. Early studies on roles of
bacterial LPS in triggering acute intestinal inflammation revealed
that LPS-hyporesponsive C57BL and C3H mice displayed
reduced macroscopic signs of colitis as compared to controls and
were protected from inflammatory responses initiated by elevated
serum LPS levels during inflammation [16]. Another study
reported that DSS-induced colitis activity varies with the mouse
strain used, but claims that the severity of colitis does not differ in
LPS-unresponsive as compared to control mice, irrespective of
their genetic background [17]. Furthermore, TLR-mediated
sensing of gut bacteria has been suggested to play a role in
intestinal homeostasis and TLR4 was shown to limit bacterial
translocation during colitis [18–21]. In contrast, recent findings
demonstrated that TLR-signaling via the adapter protein MyD88
is essential for spontaneous development of colitis in IL10-deficient
mice [22]. However, global gut flora analysis in DSS-induced
barrier-damage, which could account for some of the contradic-
tory results mentioned above, has not been performed and
bacterial species most abundant in acute colitis have not been
investigated so far. To further extend our knowledge on potential
roles ofa bacterial interplay with innateimmunity inacute colitis,we
performed a global survey of the intestinal microflora and
determined numbers of inflammatory cells in DSS-treated
C57BL/10 mice lacking TLRs 2 and/or 4. Because major groups
of gut bacteria cannot be cultivated, we complemented classical
microbiological analyses with culture-independent molecular ap-
proaches such as denaturing-gradient-gel-electrophoresis (DGGE)
based on separation of PCR-amplified bacterial 16S rRNA gene
fragments [8,14]. Besides identification of gut residents specifically
associated with the severity of DSS-induced colitis, we also studied
the impactofTLRs2and4on i)macroscopicsignsofacutecolitis,ii)
changes in relevant immune cell populations in the inflamed colon,
and iii) the composition and dynamics of the intestinal microflora in
healthy and diseased TLR-deficient animals.
RESULTS
Severity of acute intestinal inflammation depends
on TLR2- and TLR4-signaling
We have recently demonstrated that commensal E. coli increase and
exacerbate small intestinal inflammation in C57BL/10 mice via
LPS-mediated TLR4-signaling [8,14]. To determine whetherTLR2
or TLR4 may be involved in the aggravation of acute colitis, we
compared macroscopic signs of disease in C57BL/10 wild-type (wt)
mice and animals lacking TLR2, TLR4, or both (Figure 1). After
seven days of DSS-treatment, wt mice developed severe signs of
colitis as indicated by a total clinical score of 11.361 (Figure 1A). In
contrast, TLR2
-/-,T L R 4
-/-, and TLR2/4
-/- animals displayed
significantly (P,0.001) lower clinical scores of 7.161.6, 7.063, and
4.262.3, respectively, as compared to wt animals, thus indicating
that colitis is exacerbated via TLR2- and TLR4-signaling
(Figure 1A). Furthermore, reduced macroscopic signs of colitis in
TLR2
-/-,T L R 4
-/-, and TLR2/4
-/- were associated with diminished
inflammatory activity as demonstrated by lower IFN-gamma
concentrations (Figure 1B) in colonic mesenteric lymph nodes.
TLR2- and TLR4-dependent accumulation of effector
immune cells in the inflamed colon
The acute stage of DSS-colitis is characterized by recruitment of
neutrophils and T-cells to damaged tissue areas [23]. In addition,
there is strong evidence that regulatory T-cells accumulate at
inflamed tissue sites in DSS-treated mice and in IBD patients
[23,24]. However, their numbers in diseased animals have not
been investigated so far. Therefore, we quantified CD3
+ total T-
cells, FOXP3
+ regulatory T-cells, and myeloperoxidase
+ neutro-
phils by immunohistochemistry of colon sections in situ. The results
demonstrated that numbers of CD3
+ T-cells were slightly
increased in the colons of DSS-treated wt and TLR2-deficient,
but not TLR4- and TLR2/4-deficient mice, as compared to the
respective naive animals (Figure 2). Most strikingly, the numbers of
neutrophils and FOXP3
+ regulatory T-cells in the inflamed colon
were significantly lower in the colons of TLR2
-/-, TLR4
-/-, and
TLR2/4
-/- mice as compared to DSS-treated wt animals
(Figure 2). Independent histochemical analyses of HE-stained
tissue sections and histological scoring by two pathologists (C.L.
and H.A.L.) showed that DSS-induced tissue damage and
histopathological changes in the colon were similar in wt,
TLR2
-/-, and TLR4
-/- mice, but significantly reduced in TLR2/
4
-/- mice, as compared to the wt animals (not shown).
Development of a complex gut flora in TLR2
-/- and
TLR4
-/- mice
To determine whether sensing of gut bacteria via TLR4 or TLR2
has a general impact on the composition of the intestinal
Figure 1. Colitis severity and inflammatory responses in TLR2
-/-,
TLR4
-/-, and TLR2/4
-/- mice, as compared to wt controls. (A) Severity of
colitis in DSS-treated animals. Clinical outcome of colitis was recorded
in wt mice (WT, n=10) and in mice lacking TLR2 (TLR2
-/-, n=10), TLR4
(TLR4
-/-, n=12), or both (TLR2/4
-/-, n=11). Clinical parameters of colitis
were monitored daily (see methods). The data sets from two
independent experiments were pooled. Total colitis scores were
analyzed at day eight after DSS-treatment for seven days.
(B) IFN-gamma concentrations in supernatants of colonic MLN cultures
from wt and TLR-deficient animals. Supernatants from MLN cultures of
wt mice (WT, black bars, n=3), and animals lacking TLR2 (TLR2
-/-, n=4),
TLR4 (TLR4
-/-, n=5), or both (TLR2/4
-/-, n=4) with colitis were analyzed
at day eight after DSS-treatment for seven days.
(A/B) Mean values, standard deviations and significance levels (as
compared to the wt animals) determined by Student’s t-test are
indicated (
***, P,0.001).
doi:10.1371/journal.pone.0000662.g001
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performed a global molecular survey of the colon microbiota in
healthy C57BL/10 mice lacking TLR2, TLR4, or both receptors
(Figure 3). Therefore, offspring mice were sacrificed, and the
bacterial communities within the colon characterized by analysis
of cloned bacterial 16S rRNA genes in DNA libraries (Figure 3A),
as well as by high-resolution DGGE (Figure 3B). Comparative
analysis of 16S rRNA gene libraries revealed that the overall
diversity and composition of the gut microflora did not differ
significantly among healthy TLR2
-/-, TLR4
-/-, and TLR2/4
-/-
mice, as compared to wt animals (Figure 3A). The number and
position of bands in DGGE profiles showed that the molecular
pattern of the colon flora of TLR2
-/-, TLR4
-/-, and TLR2/4
-/-
mice were similar to the reference pattern of wt animals, showing
100%, 92%, and 92% concordance, respectively. Two DGGE
bands that were less intense in mice lacking TLR4 (Figure 3B, grey
arrows) when compared to wt or TLR2
-/- animals contained DNA
from so far uncultured bacteria of the Bacteroidales group
(Figure 3B). The fact that i) bacteria represented by the upper
band completely absent in TLR4
-/- mice were present in the
luminal colon contents from TLR4
-/- animals that grew up in
another facility (Figure 3B, black arrow), and ii) that the lower
band was detected in one of the TLR4
-/- animals (Figure 3B)
provided strong evidence that these differences are most likely
caused by interindividual variability.
Characterization of gut flora changes in acute colitis
In order to characterize potential gut flora shifts during DSS-
induced barrier damage and to identify gut residents abundant in
colitis, we performed a global survey of the gut flora in C57BL/10
mice with or without colitis (Figures 4A and 5). Molecular
monitoring of the intestinal bacterial communities by DGGE
(Figure 4A) demonstrated that the acute stage of colitis was
characterized by a shift towards members of the Enterobacteriaceae
(Figure 4A). In addition, bacterial communities in the colon from
diseased mice were less complex, indicating a loss in bacterial
diversity during acute inflammation (Figure 4A). Sequence analysis
of bacterial 16S rRNA gene fragments from individual DGGE
bands revealed that previously undescribed members of the
Figure 2. Quantification of immune cells in the colon of DSS-treated
mice. Numbers of T-cells, regulatory T-cells, and neutrophils in the
colon of DSS-treated wt mice and mice lacking TLR2 and/ or TLR4. The
average number of cells positive for CD3, FOXP3, or myeloperoxidase
from at least five high power fields (HPF, 4006magnification) per animal
were determined microscopically in immunostained colon sections of
wt mice (WT), and animals lacking TLR2 (TLR2
-/-), TLR4
-/- (TLR4
-/-), or
both (TLR2/4
-/-) at day eight after DSS-treatment for seven days (C, grey
circles). Healthy animals served as controls (H, white circles). The
numbers of analyzed animals are given in parenthesis. Mean values
(black bars), and significance levels (as compared to wt animals with
colitis) determined by Student’s t-test are indicated (
*, P,0.05;
**,
P,0.01;
***, P,0.001).
doi:10.1371/journal.pone.0000662.g002
Figure 3. Molecular gut flora analysis in mice lacking TLR2 and/or
TLR4. Detailed molecular investigations of the colon microbiota in three
months old C57BL/10 mice lacking TLR2, TLR4, or both were performed
by analysis of 16S rRNA gene libraries (A) or high-resolution DGGE (B)
with primers HDA-1-GC and HDA-2 (see methods).
(A) Results from gene library analysis. Complete 16S rRNA genes were
amplified from total luminal colon content DNA isolated from wt mice
(WT, n=3), and from mice (n=3 each group) lacking TLR2 (TLR2
-/-),
TLR4 (TLR4
-/-), or both (TLR2/4
-/-). The amplicons were cloned and
sequenced as described in the Methods section. Bars represent
percentage amounts of gut bacterial groups indicated on the Y-axis.
(B) Results from DGGE analysis of PCR-amplified total bacterial 16S rRNA
gene fragments. Each lane shows DGGE profiles of the bacterial flora
from the colon of healthy wt mice, and animals lacking TLR2 (TLR2
-/-),
TLR4 (TLR4
-/-), or both (TLR2/4
-/-). Mice of identical age (three months)
originated from two different animal facilities (as indicated above the
lanes). DNA bands, which were absent or weak in DGGE profiles from
TLR4
-/- and TLR2/4
-/- animals are marked by grey arrows. Bacterial
species identified by sequence analysis of 16S rRNA gene fragments in
the corresponding bands are indicated on the left. Total numbers of
DGGE bands in the profile from wt animals were counted and set to
100% in the reference pattern (RP). Presence and absence of bands in
profiles from the respective TLR-deficient animals was recorded and
similarity values were calculated and expressed as % similarity to the wt
RP. The DGGE profiles are representative for at least three mice per
group and experiment. Results were reproduced in two independent
experiments.
doi:10.1371/journal.pone.0000662.g003
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lactobacilli disappeared and were not detected in the inflamed
colon (Figure 4A). In contrast, a DGGE band containing 16S
rRNA genes from bacteria of the Clostridiales group was more
prominent in samples from the inflamed colon, providing evidence
that these bacteria might accumulate during colitis.
A global culture analysis of the gut flora in the inflamed colon of
DSS-treated wt mice revealed that concentrations of commensal
E. coli increased significantly (P,0.001) by four orders of
magnitude, respectively (Figure 5A). Populations of Bacteroides/
Prevotella spp., enterococci, clostridia and lactobacilli were not
significantly altered in the inflamed colon (Figures 5A and 5B).
Thus, cultural analyses confirmed that the development of colitis is
accompanied by shifts in the luminal E. coli population.
Identification of gut flora changes associated with
the severity of acute intestinal inflammation
The fact that macroscopic signs and inflammatory parameters of
acute intestinal inflammation were reduced in TLR2
-/-, TLR4
-/-,
and TLR2/4
-/- mice prompted us to identify distinct gut bacterial
populations associated with colitis severity (Figure 4B and
Figure 5). A molecular analysis of the colon microflora
composition in DSS-treated TLR2/4
-/- animals by DGGE
revealed that the intensities of DNA-bands of Enterobacteriaceae
were weaker when compared to wt animals (compare Figures 4A
and B). Furthermore, TLR2/4
-/- mice did not display an increased
intensity of the DNA band containing a 16S rRNA gene fragment
from so far undescribed clostridia (Figure 4B) observed in DSS-
treated wt animals (Figure 4A). Most strikingly, a detailed culture-
based comparative analysis of the intestinal flora demonstrated
that E. coli concentrations increased to a lesser degree in DSS-
treated TLR2- and TLR4-deficient animals as compared to wt
mice (P,0.01), indicating that increased colitis severity is
associated with higher E. coli loads (Figure 5A). In TLR2/4
-/-
mice, the increase in the E. coli numbers was also strongly
alleviated, if compared to wt mice (P,0.001), and these mice
displayed only an approximately 10-fold rise in E. coli after colitis
induction (Figure 5A). Moreover, DSS-treated TLR2/4
-/- mice
contained significantly lower luminal loads of Bacteroides/Prevotella
spp. and enterococci as compared to wt mice (P,0.01), whereas all
other flora changes in the respective TLR-deficient mice did not
significantly differ from those observed in wt controls (Figure 5).
Biochemical analyses revealed that the Bacteroides population
consisted of B. ovatus, B. merdae, B. uniformis, B. vulgatus, and
B. thetaiotaomicron. Prevotella spp. were represented by P. oralis and
P. buccae. Enterococcus spp. included E. faecalis, E. faecium, and
E. gallinarum.
DISCUSSION
The first global and comprehensive analysis of the colon
microflora in the DSS-induced colitis model revealed that acute
barrier-damage in the colon is accompanied by accumulation of
commensal E. coli. Because intestinal overgrowth occurs in
different intestinal injuries [25], these flora shifts are most possibly
caused by a breakdown of the mucosal physiology. Together with
the finding that the lack of TLRs 2 and/or 4 per se had no impact
on the composition of the intestinal microflora in healthy mice
(Figure 3), the lower abundance of E. coli in TLR-deficient mice
with less macroscopic disease symptoms indicates that E. coli can
serve as a sensitive biomarker for colitis severity. This is in line
with the earlier finding that commensal E. coli accumulated
drastically during ileitis in our C57BL/10 mice and displayed
a strong pro-inflammatory potential to trigger small intestinal
inflammation via TLR4 [8,14]. Similarly, abundant numbers of E.
coli were associated with inflammation in the colon of IL2
-/- mice
[26]. Contributions of E. coli and other gut bacteria to the
aggravation of colitis were shown earlier in mono-associated germ-
free IL10
-/- and IL2
-/- mice [27-29] and by the curative effects of
antimicrobial therapy [15,30,31]. Nevertheless, mechanisms by
which accumulating E. coli may modulate DSS-induced acute
colitis are still not known in detail. The reduced macroscopic signs
of colitis displayed by the DSS-treated TLR2
-/-, TLR4
-/-, and
TLR2/4
-/- mice point towards important roles of LPS and TLR2
ligands (such as lipopeptides) in acute inflammatory processes in
the colon. In the C57BL/10 mice analyzed here, both ligands
seem to potentiate inflammation by TLR-mediated recruitment of
neutrophils to inflamed tissue sites. The fact that FOXP3-positive
cells were significantly decreased in DSS-treated TLR2
-/-,
TLR4
-/-, and TLR2/4
-/- mice suggests that TLR ligands foster
the recruitment and/or proliferation of regulatory T-cells, which
can serve as markers for acute intestinal inflammation in this
animal model. This is consistent with similar observations in IBD,
where inflamed tissue areas contained higher numbers of FOXP3-
positive T-cells [24]. Taken together and in line with recent
findings [18-21], our results underline the important role of gut
bacterial sensing by TLRs in maintaining the intricate balance
between mucosal immunity and intestinal inflammation.
The results obtained here add important information in as
much as bacterial TLR2 ligands may contribute to colitis
Figure 4. Molecular analysis of predominant bacterial communities
in the colon of healthy and diseased mice.
(A) DGGE profiles of the colon flora in healthy and diseased wt mice.
Results are shown for C57BL/10 wt mice without DSS-treatment or at
day eight after DSS-treatment for seven days (as indicated above the
lanes). Bacterial species were identified by comparative sequence
analyses of 16S rRNA gene fragments amplified from DNA eluted from
respective DNA bands. The DGGE profiles are representative for at least
three mice per group and experiment.
(B) DGGE profiles of the colon flora in healthy and diseased TLR2/4
-/-
mice. DGGE profiles of luminal intestinal bacteria from wt and TLR2/4
-/-
mice were generated by PCR-based analysis of total DNA from colon
contents of mice with or without colitis at day eight after DSS-
treatment for seven days (as indicated). Bacterial species were identified
by comparative sequence analysis of 16S rRNA gene fragments
amplified from DNA eluted from respective DNA bands. The DGGE
profiles are representative for at least three mice per group and
experiment.
(A/B) Primers GC968F and R1378 (Heimesaat et al., 2006) were used for
amplification. Results were reproduced in at least two independent
experiments.
doi:10.1371/journal.pone.0000662.g004
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cultured Gram-positive bacteria of the Clostridium group increased
during colitis (as shown by DGGE). Furthermore, the inflamed
colon of DSS-treated TLR2/4
-/- animals displaying reduced
disease symptoms contained significantly lower concentrations of
Bacteroides/Prevotella spp. and enterococci, as compared to wt-
controls. However, since DGGE is not a quantitative technique
and because the enterococcus concentrations showed only
a tendency to increase during colitis, the potential impact of these
observations remains speculative.
In conclusion, DSS-induced colitis is accompanied by a popu-
lation shift towards E. coli, which have the potential to trigger
TLR-dependent accumulation of neutrophils and T-cells. This
microflora shift towards pro-inflammatory bacteria may help to
explain why blockage of TLR-signaling was successfully used to
suppress acute intestinal inflammation [32]. Thus, DSS-induced
barrier damage seems to be a valuable model to further identify
bacterial factors involved in maintaining intestinal homeostasis
and to test therapeutic interventions based upon anti-TLR
strategies.
MATERIALS AND METHODS
Mice, colitis induction and determination of clinical
scores
C57BL/10ScSn wt, TLR2
-/-, TLR4
-/-, and TLR2
-/-/TLR4
-/-
mice were bred as described [8,14]. Experiments were conducted
according to the German animal protection laws. For colitis
induction, mice were treated with 3.5% (wt/vol) DSS
(40.000 kDa, MP Biomedicals, Illkirch, France) in drinking water
ad libitum for seven days. Prior to sacrifice, mice received water
without DSS for 24 hours. The intake of the DSS-solution was
controlled and mice were weighed daily. Total clinical scores with
a maximum of 12 were assessed daily by combined data of
weightloss, occurance of blood in stool (Haemoccult
TM, Beckman
Coulter / PCD, Krefeld, Germany), and stool consistence, as
described [33].
Sampling procedures and histologic scoring
Mice were sacrificed with Halothan
TM (Eurim-Pharm, Mu ¨lheim,
Germany) on day eight after induction of colitis. Colon samples
Figure 5. Cultural analysis of gut flora changes in healthy and diseased TLR2
-/-, TLR4
-/-, and TLR2/4
-/- mice, as compared to wt controls. Bacterial
counts of (A) Gram-negative (E. coli, Bacteroides/ Prevotella spp.) and (B) Gram-positive bacteria (Enterococcus spp., clostridia and lactobacilli) in
luminal colon contents from healthy animals (H) and from mice with colitis at day eight after DSS-treatment for seven days (C) as determined by
culture. Bacterial species were identified by biochemical analysis and reconfirmed by comparative sequence analyses of 16S rRNA genes. Results are
shown for wt mice (WT, above) and for mice lacking TLR2 (TLR2
-/-), TLR4 (TLR4
-/-), or both (TLR2/4
-/-) as indicated on the x-axis. Animal numbers
analyzed are given in parentheses. The data sets were pooled from two independent experiments. The boxes represent 75th % and 25th %
percentiles of medians (indicated by black bars within the boxes. Maximum and minimum values are indicated by lines above and below boxes,
respectively. Significance levels were determined by Mann-Whitney-U-Test. Underlined P values shown in black were calculated from comparisons of
healthy versus diseased animals. P values shown in grey were calculated from the bacterial number in diseased animals (all versus WT).
doi:10.1371/journal.pone.0000662.g005
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investigated in paraffin-embedded HE-stained tissue sections. A
published standardized histologic score [33] ranging from 0 to 6
was used for blinded evaluation of the inflammatory processes in
the colon.
Immunohistochemistry
For immunostaining, 4 mm sections of formalin-fixed, paraffin-
embedded tissue were cut, deparaffinized, and subjected to a heat-
induced epitope retrieval step. Slides were rinsed in cool running
water, washed in Tris-buffered saline (pH 7.4) before incubation
with primary antibodies against CD3 (N1580, Dako, Glostrup,
Denmark, dilution 1:10), myeloperoxidase (MPO7, A0398, Dako,
1:10000), and Foxp3 (FJK-16s, eBioscience, 1:100) for 30 min. For
detection, biotinylated donkey anti-rat (Dianova, Hamburg,
Germany) or rabbit anti-rat (Dako) secondary antibodies were
used followed by application of the streptavidinAP kit (K5005,
Dako) or the EnVision peroxidase kit (K 4010, Dako). Alkaline
phosphatase was revealed by Fast Red as chromogen and
Peroxidase was developed with a highly sensitive diaminobenzi-
dine (DAB) chromogenic substrate for approximately 10 minutes.
Negative controls were performed by omitting the primary
antibody. For each animal, the average number of positive stained
cells within at least five independent high power fields (HPF,
4006magnification) were determined microscopically and sub-
jected to statistical analysis as indicated.
Analysis of the colon microflora
Molecular detection, biochemical identification, and cultural
analyses of intestinal bacterial communities were performed as
described [8,14,34]. Briefly, luminal feces samples were removed
for molecular analyses from the distal colon, resuspended in PBS,
and centrifuged (16,0006g/10 min/4uC). Total DNA, isolated by
phenol extraction as described [8], served as template for PCR
amplification of bacterial 16S rRNA genes with consensus primers
TPU1 (59-AGAGTTTGATCMTGGC TCAG-39, nt 8-27 in the
E. coli 16S rRNA gene) / RTU8 (59-AAGGAGGTGATC-
CANCCRCA-39, nt 1541-1522 in the E. coli 16S rRNA gene).
Gene libraries of the amplicons were constructed and analyzed as
described [34]. For high-resolution DGGE, which yielded the
highest numbers of individual bands from a given sample, the
variable region V3 in bacterial 16S rRNA genes was amplified
from total gut content DNA with GC clamp (underlined) primer
HDA-1-GC (59-GCCCGGGGCGCGCCCCGGGCGGGGCG-
GGGGC ACGGGGGGACTCCTACGGGAGGCAGCAGT-39,
nt 339-360 in the E. coli 16S rRNA gene) and primer HDA-2 (59-
GTATTACCGCGGCTGCTGGCAC-39, nt 539-518 in the E.
coli 16S rRNA gene).
Determination of IFN-gamma concentrations
MLNs were removed and incubated in 24-flat-bottom well culture
plates (Nunc, Wiesbaden, Germany) containing 500 ml serum-free
RPMI medium supplemented with penicillin/ streptomycin for
18 h at 37uC. IFN-gamma concentrations in supernatants were
determined by ELISA as described [8,14].
Statistical analysis
Mean values, medians, standard deviations and levels of signifi-
cance were determined using Student’s t-test and the Mann-
Whitney-U-Test as indicated. Two-sided probability (P) values#
0.05 were considered significant. All experiments were repeated at
least twice.
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